Suchergebnisse - "Tibes, R"

PubPharm (30)

1

Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis

enthalten in: Leukemia research | 2017

von Gowin, K. | Kosiorek, H. | Dueck, A. | +8

2

Pegylated interferon alpha - 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial

enthalten in: Leukemia research | 2017

von Gowin, K. | Jain, T. | Kosiorek, H. | +4

3

Pegylated interferon alpha – 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial

enthalten in: Leukemia research | 2017

von Gowin, K. | Jain, T. | Kosiorek, H. | +4

4

Sonidegib phosphate : new approval for basal cell carcinoma

enthalten in: Drugs of today (Barcelona, Spain : 1998) | 2016

von Tibes, R.

5

Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients

enthalten in: Blood cancer journal | 2016

von Kortuem, K. | Braggio, E. | Bruins, L. | +13

6

Sonidegib phosphate: new approval for basal cell carcinoma

enthalten in: Drugs of today | 2016

von Tibes, R.

7

Sonidegib phosphate: new approval for basal cell carcinoma

enthalten in: Drugs of today | 2016

von Tibes, R.

8

Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2016

von Leijen, S. | van Geel, R. | Pavlick, A. | +13

9

Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias

enthalten in: Investigational new drugs | 2015

von Tibes, R. | McDonagh, K. | Lekakis, L. | +13

10

Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias

enthalten in: Investigational new drugs | 2014

von Tibes, R. | McDonagh, K. | Lekakis, L. | +13